Skip to main content
Premium Trial:

Request an Annual Quote

Rosalind Partners with Geninus, Helixrus to Bring Single-Cell Software to Asian Markets

NEW YORK – San Diego-based bioinformatics firm Rosalind said on Thursday that it has partnered with Seoul-based firms Geninus and Helixrus to bring its single-cell sequencing data analysis platform to South Korea and other Asian Markets.

Genomics services provider Geninus will combine Rosalind's platform with its Celinus single-cell RNA sequencing service. Helixrus will provide local support services for the Rosalind platform.

Financial and other details of the agreements were not disclosed.

Rosalind, formerly known as OnRamp Bioinformatics, rebranded last month and launched its diagnostic monitoring platform for SARS-CoV-2 Variants.

Last month Geninus partnered with Ocean Genomics to develop RNA-based cancer biomarkers.

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.